Ekati Drakopoulou

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Sickle Cell Disease

Peritoneal Dialysis

Endoplasmic Reticulum Stress

Patient Reported

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Eleni Kalafati, Ekati Drakopoulou, Nicholas P Anagnou, Kalliopi I Pappa
Developing Oncolytic Viruses for the Treatment of Cervical Cancer. Cells 12 (14) (2023)
Ekati Drakopoulou, Maria Georgomanoli, Carsten Werner Lederer, Fottes Panetsos, Marina Kleanthous, Ersi Voskaridou, Dimitrios Valakos, Eleni Papanikolaou, Nicholas P Anagnou
The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34 + Cells from Sickle Cell Disease Patients. Viruses 14 (12) (2022)
Ekati Drakopoulou, Maria Georgomanoli, Carsten Werner Lederer, Fottes Panetsos, Marina Kleanthous, Ersi Voskaridou, Dimitrios Valakos, Eleni Papanikolaou, Nicholas P Anagnou
The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34 + Cells from Sickle Cell Disease Patients. Viruses 14 (12) (2022)
Ekati Drakopoulou, Maria Georgomanoli, Carsten Werner Lederer, Fottes Panetsos, Marina Kleanthous, Ersi Voskaridou, Dimitrios Valakos, Eleni Papanikolaou, Nicholas P Anagnou
The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34 + Cells from Sickle Cell Disease Patients. Viruses 14 (12) (2022)
Ekati Drakopoulou, Maria Georgomanoli, Carsten Werner Lederer, Fottes Panetsos, Marina Kleanthous, Ersi Voskaridou, Dimitrios Valakos, Eleni Papanikolaou, Nicholas P Anagnou
The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34 + Cells from Sickle Cell Disease Patients. Viruses 14 (12) (2022)
Ekati Drakopoulou, Maria Georgomanoli, Carsten Werner Lederer, Fottes Panetsos, Marina Kleanthous, Ersi Voskaridou, Dimitrios Valakos, Eleni Papanikolaou, Nicholas P Anagnou
The Optimized γ-Globin Lentiviral Vector GGHI-mB-3D Leads to Nearly Therapeutic HbF Levels In Vitro in CD34 + Cells from Sickle Cell Disease Patients. Viruses 14 (12) (2022)